FDA Must Quit Delaying and Stop Mail-Order Abortions Now
Catherine Pressly Herring was pregnant with her third child when her husband secretly slipped one of the drugs used in chemical abortion into her drinks in an attempt to cause an abortion without her knowledge. He did it repeatedly.
Catherine became violently ill and began bleeding. Her daughter survived but was born 10 weeks premature. Her husband eventually pleaded guilty to assault of a pregnant person and injury to a child. He was sentenced to 180 days in jail and 10 years of probation. After later violating a protective order, his probation was revoked and he was sentenced to eight years in prison.
In October, the U.S. Food and Drug Administration provided a court-ordered update on the safety review of the chemical abortion drug mifepristone. In it, the report release date was postponed until March 2027. The administration has been dragging its feet on needed action on the abortion pill for more than a year.
The FDA should pull the abortion pill from the market. At the very least, the administration should end mail-order abortion until a permanent solution is in place. Millions of unborn children have already lost their lives through chemical abortion, and it is far past time to act.
Follow LifeNews on the MeWe social media network for the latest pro-life news free from Facebook’s censorship!
In fact, the available data show the abortion pill is not safe and effective as labeled today. Chemical abortion now accounts for about 65 percent of human lives ended by abortion in the U.S., according to the Guttmacher Institute’s current national data. In 2020, the figure was 53 percent.
Those percentages represent millions of dead American children.
The FDA approves mifepristone as part of the chemical abortion regimen through 10 weeks of pregnancy. By that point, the child has already undergone weeks of rapid development. Her arms and legs are taking shape, her fingers and toes are visible, and her major organ systems have begun developing.
The abortion pill Mifepristone blocks progesterone, a hormone needed to sustain the pregnancy. Misoprostol is then taken to cause contractions and expel the child. The purpose of the two-drug regimen is abortion: to end the child’s life.
Over the last two decades, the FDA has tragically made these drugs easier and easier to obtain. Mifepristone was originally approved in 2000 with far more restrictive rules. In 2016, the FDA extended approved use from the first seven weeks of pregnancy to 10 weeks and loosened other requirements. The agency later eliminated the in-person dispensing requirement, so that abortion pills can now be prescribed remotely and sent through the mail.
An individual can now receive abortion drugs without ever sitting in the same room as the doctor prescribing them.
There is also crucial evidence about the risks women face. The Ethics and Public Policy Center conducted the largest study on the real-world effect of the abortion pill by analyzing insurance claims associated with 865,727 prescribed mifepristone abortions from 2017 through 2023. It found that nearly 11 percent involved what it classified as serious adverse events within 45 days, including sepsis, infection and hemorrhaging.
My organization investigated how Planned Parenthood sent out these abortion pills with no safeguards. At multiple locations across the country, investigators were told women could obtain mifepristone through telehealth without even an ultrasound to confirm gestational age. Without that screening, an ectopic pregnancy can go undetected. Abortion pills do not treat ectopic pregnancies — a rupture can cause catastrophic internal bleeding and even death.
Failure to confirm gestational age can also mean women take the drugs much later in pregnancy, increasing the risks of severe hemorrhage, infection, and other serious complications. Multiple facilities even said that the pills could be mailed to someone else’s home and kept for later use. The investigation exposed a reckless system distributing powerful abortion drugs with remarkably little medical oversight, leaving women vulnerable to dangerous and potentially life-threatening complications
Catherine Herring’s case makes that danger impossible to dismiss — nor is it by any means the only one (in the U.S. or abroad) in which abortion drugs are being weaponized against women and their children in utero by people who had no business acquiring them. Every abortion kills a baby, and in many cases like Catherine’s, it is also a crime against the mother.